Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes : modulation by gender

Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes : modulation by gender / Katia Collomp, Corinne Buisson, Nicolas Gravisse, Soraya Belgherbi, Zakaria Labsy, Manh-Cuong Do, Olivier Gagey, Sophie Dufay, Nancy Vibarel-Rebot, Michel Audran. - (Endocrine 59 (2018) 3 (March); p. 538-546).
- PMID: 29322301.
- DOI: 10.1007/s12020-017-1514-z


Dehydroepiandrosterone (DHEA) figures on the World Anti-Doping Agency list of prohibited substances in sport because it is assumed that athletes expect a significant increase in testosterone through DHEA administration. The literature on the hormonal effects of DHEA intake nevertheless appears to be very scant in healthy young subjects, especially women.

We examined the effects of DHEA on adrenal and gonadal hormones, IGF1 and free T3 in healthy young male and female recreationally trained volunteers.

The study followed a double-blind, randomized-order crossover design. Lean healthy young men (n = 10) and women (n = 11), with all women using oral contraceptives, were treated daily with 100 mg of DHEA and placebo for 4 weeks. DHEA, DHEA-sulfate (DHEA-S), androstenedione, total testosterone (Tes), dihydrotestosterone (DHT), SHBG, estrone, cortisol, IGF1, and free T3 were measured before, in the middle and at the end of each treatment, as were blood glucose, liver transaminases and lipid status.

We observed a significant increase in DHEA, DHEA-S, androstenedione, Tes, DHT, and estrone in both men and women in the middle and at the end of DHEA treatment, but the increase in Tes was more marked in women (p < 0.001) than men (p < 0.05). No changes were found in the other parameters, irrespective of gender.

In young athletes, DHEA administration induces significant blood hormonal changes, some modulated by gender, which can be used as biomarkers of doping


Research / Study
10 January 2018
Audran, Michel
Belgherbi, Soraya
Buisson, Corinne
Collomp, Katia
Do, Manh-Cuong
Dufay, Sophie
Gagey, Olivier
Gravisse, Nicolas
Labsy, Zakaria
Vibarel-Rebot, Nancy
Other organisations
Université d'Orléans - University of Orléans
Université Paris-Sud - Paris-Sud University
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S1. Anabolic Agents
Androstenedione (androst-4-ene-3,17-dione)
Dihydrotestosterone (17β-hydroxy-5α-androstan-3-one)
Prasterone (dehydroepiandrosterone, DHEA, 3β-hydroxyandrost-5-en-17-one)
Medical terms
Health effects
Document category
Date generated
17 October 2019
Date of last modification
21 October 2019
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period